We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$37.3M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$31.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Newmont
NEM
|
+$27.4M |
| 5 |
Cummins
CMI
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$430M |
| 2 |
JPMorgan Chase
JPM
|
+$168M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 4 |
Yum! Brands
YUM
|
+$105M |
| 5 |
Pfizer
PFE
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PDS Biotechnology
PDSB
$38.1M
| $267K | ﹤0.01% |
+32,906
| New | +$354K |
|
852
Airbnb
ABNB
$83.7B
| $266K | ﹤0.01% |
1,596
+236
| +17% | +$41.6K |
|
853
FMC
FMC
$1.42B
| $266K | ﹤0.01% |
2,421
-526
| -18% | -$52.9K |
|
|
BDSI
854
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $265K | ﹤0.01% |
85,462
+1,710
| +2% | +$5.75K |
|
855
Amdocs
DOX
$5.53B
| $258K | ﹤0.01% |
+3,450
| New | +$259K |
|
856
Tapestry
TPR
$28.8B
| $257K | ﹤0.01% |
+6,323
| New | +$260K |
|
|
SURF
857
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $255K | ﹤0.01% |
+53,388
| New | +$345K |
|
858
Cincinnati Financial
CINF
$28.3B
| $254K | ﹤0.01% |
+2,229
| New | +$264K |
|
859
Regions Financial
RF
$26.3B
| $251K | ﹤0.01% |
+11,520
| New | +$263K |
|
860
Waste Management
WM
$95.9B
| $251K | ﹤0.01% |
+1,505
| New | +$242K |
|
|
CLR
861
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $248K | ﹤0.01% |
+5,530
| New | +$263K |
|
862
Cigna
CI
$76.6B
| $238K | ﹤0.01% |
+1,038
| New | +$221K |
|
863
O-I Glass
OI
$1.39B
| $238K | ﹤0.01% |
19,765
-3,568
| -15% | -$45.2K |
|
864
Atossa Therapeutics
ATOS
$22.8M
| $234K | ﹤0.01% |
+9,769
| New | +$357K |
|
|
INFI
865
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $232K | ﹤0.01% |
103,021
-5,720
| -5% | -$14.4K |
|
866
Axalta
AXTA
$7.01B
| $231K | ﹤0.01% |
6,981
-1,454
| -17% | -$46.1K |
|
|
IMPL
867
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $230K | ﹤0.01% |
+26,662
| New | +$266K |
|
868
Domino's
DPZ
$11B
| $223K | ﹤0.01% |
395
-3,032
| -88% | -$1.54M |
|
869
Moderna
MRNA
$21.5B
| $220K | ﹤0.01% |
867
+18
| +2% | +$5.26K |
|
870
Middleby
MIDD
$6.05B
| $214K | ﹤0.01% |
+1,087
| New | +$198K |
|
871
INmune Bio
INMB
$43.1M
| $211K | ﹤0.01% |
20,650
-1,049
| -5% | -$15.5K |
|
872
Upstart Holdings
UPST
$2.58B
| $209K | ﹤0.01% |
1,379
+28
| +2% | +$6.99K |
|
873
BeyondSpring
BYSI
$46.1M
| $205K | ﹤0.01% |
+45,266
| New | +$511K |
|
874
Exelixis
EXEL
$13.9B
| $202K | ﹤0.01% |
11,070
-2,410
| -18% | -$46.1K |
|
875
Wendy's
WEN
$1.33B
| $202K | ﹤0.01% |
8,482
-1,746
| -17% | -$38.8K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.
By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.
Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.
- ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
- ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
- ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
- ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
- ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
- ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.
Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.